Stratos Wealth Partners LTD. Boosts Holdings in Lam Research Corporation $LRCX

Stratos Wealth Partners LTD. increased its holdings in Lam Research Corporation (NASDAQ:LRCXFree Report) by 10.2% in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 111,531 shares of the semiconductor company’s stock after purchasing an additional 10,280 shares during the period. Stratos Wealth Partners LTD.’s holdings in Lam Research were worth $14,934,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. IMG Wealth Management Inc. bought a new stake in Lam Research in the second quarter worth $26,000. Howard Hughes Medical Institute purchased a new position in shares of Lam Research in the second quarter worth about $27,000. Sound Income Strategies LLC bought a new stake in shares of Lam Research in the 3rd quarter valued at about $41,000. Tripletail Wealth Management LLC purchased a new stake in Lam Research during the 3rd quarter valued at about $44,000. Finally, Strategic Wealth Investment Group LLC bought a new position in Lam Research during the 2nd quarter worth approximately $29,000. Institutional investors own 84.61% of the company’s stock.

Lam Research Stock Down 1.2%

Shares of NASDAQ LRCX opened at $226.61 on Wednesday. The firm has a fifty day simple moving average of $197.23 and a two-hundred day simple moving average of $152.89. Lam Research Corporation has a 12 month low of $56.32 and a 12 month high of $251.87. The company has a current ratio of 2.26, a quick ratio of 1.61 and a debt-to-equity ratio of 0.37. The firm has a market capitalization of $282.98 billion, a PE ratio of 46.44, a price-to-earnings-growth ratio of 2.46 and a beta of 1.78.

Lam Research (NASDAQ:LRCXGet Free Report) last announced its earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share for the quarter, beating analysts’ consensus estimates of $1.17 by $0.10. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. The firm had revenue of $5.34 billion for the quarter, compared to analyst estimates of $5.23 billion. During the same quarter in the previous year, the firm posted $0.91 EPS. The company’s revenue for the quarter was up 22.1% compared to the same quarter last year. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. Equities analysts expect that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 8th. Shareholders of record on Wednesday, March 4th will be issued a dividend of $0.26 per share. The ex-dividend date is Wednesday, March 4th. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.5%. Lam Research’s dividend payout ratio is 21.31%.

Key Stories Impacting Lam Research

Here are the key news stories impacting Lam Research this week:

  • Positive Sentiment: Multiple analyst upgrades and higher price targets reinforce upside expectations (Sanford C. Bernstein raised its target to $285; other outlets bumped targets to the mid‑$200s), supporting investor confidence. Bernstein Adjusts Price Target on Lam Research
  • Positive Sentiment: Industry and fundamentals view: commentary highlights strong AI/memory-driven demand, solid margins and $5B‑plus quarter potential — arguments used to justify a premium multiple. High P/E: Justified Premium or Too Pricey?
  • Neutral Sentiment: Technical signal: LRCX recently crossed above its 20‑day moving average, which can attract momentum traders but is a short‑term indicator. 20-Day Moving Average Crossover
  • Negative Sentiment: Insider selling: Director Eric Brandt sold 35,000 shares (~$7.9M), trimming his stake — a signal that can trigger short‑term investor caution even if not unusual for insiders to diversify. Director Sells 35,000 Shares
  • Negative Sentiment: Leadership/strategic concern: reporting on a leadership shift and the CEA‑Leti alliance prompted questions about whether recent multiple expansion is fully justified, creating valuation uncertainty for some investors. Leadership Shift And CEA Leti Alliance
  • Negative Sentiment: Options flow: unusually large put buying (roughly +112% vs. average) indicates elevated hedging or bearish positioning, which can amplify downside pressure in the near term.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the company. Deutsche Bank Aktiengesellschaft boosted their price objective on Lam Research from $260.00 to $290.00 and gave the company a “buy” rating in a research report on Thursday, January 29th. Wells Fargo & Company upped their price target on shares of Lam Research from $250.00 to $290.00 and gave the company an “overweight” rating in a report on Thursday, January 29th. Susquehanna set a $325.00 price target on shares of Lam Research and gave the company a “positive” rating in a research report on Thursday, January 29th. HSBC raised their price target on shares of Lam Research from $181.00 to $221.00 and gave the stock a “hold” rating in a report on Friday, January 30th. Finally, Summit Insights raised shares of Lam Research from a “hold” rating to a “buy” rating in a research note on Thursday, January 29th. One analyst has rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $244.88.

Get Our Latest Stock Report on Lam Research

Insider Activity at Lam Research

In related news, Director Eric Brandt sold 35,000 shares of the company’s stock in a transaction on Friday, February 6th. The stock was sold at an average price of $225.60, for a total value of $7,896,000.00. Following the sale, the director directly owned 253,705 shares of the company’s stock, valued at $57,235,848. This represents a 12.12% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Douglas R. Bettinger sold 40,080 shares of the stock in a transaction on Friday, November 14th. The stock was sold at an average price of $150.60, for a total value of $6,036,048.00. Following the completion of the transaction, the chief financial officer owned 987,237 shares of the company’s stock, valued at approximately $148,677,892.20. This trade represents a 3.90% decrease in their position. The SEC filing for this sale provides additional information. 0.31% of the stock is currently owned by corporate insiders.

Lam Research Profile

(Free Report)

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

Further Reading

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCXFree Report).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.